Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q1 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
Biotricity, Inc. last posted its earnings results on Friday, November 14th, 2025. The company reported $-0.03 earnings per share for the quarter, topping analysts' consensus estimates of $-0.08 by $0.05. The company had revenue of 3.89 M for the quarter and had revenue of 13.79 M for the year. Biotricity, Inc. has generated $-1 earnings per share over the last year ($-0.55 diluted earnings per share) and currently has a price-to-earnings ratio of -2.43. Biotricity, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 25th, 2025 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2025 | Q2 2026 | -$0.08 | -$0.03 | 0.05 | $3.90 M | $3.89 M |
| 08/14/2025 | Q1 2026 | -$0.09 | -$0.03 | 0.06 | $3.80 M | $3.87 M |
| 07/15/2025 | Q4 2025 | -$0.10 | -$0.09 | 0.01 | N/A | $3.70 M |
| 02/19/2025 | Q3 2025 | -$0.11 | -$0.05 | 0.06 | N/A | $3.62 M |
| 11/14/2024 | Q2 2025 | N/A | -$0.07 | N/A | $3.27 M | $3.27 M |
| 08/19/2024 | Q1 2025 | N/A | -$0.49 | N/A | $3.20 M | $3.20 M |
| 06/26/2024 | Q4 2024 | N/A | -$0.46 | N/A | N/A | $3.18 M |
| 02/20/2024 | Q3 2024 | -$0.41 | -$0.34 | 0.07 | N/A | $2.97 M |
| 09/29/2023 | Q2 2024 | N/A | -$0.44 | N/A | $3.30 M | $2.89 M |
| 08/14/2023 | Q1 2024 | -$0.41 | -$0.39 | 0.02 | $3.10 M | $3.02 M |
| 06/29/2023 | Q4 2023 | -$0.54 | -$0.54 | 0 | $2.60 M | $2.74 M |
| 02/14/2023 | Q3 2023 | -$0.54 | -$0.52 | 0.02 | $2.40 M | $2.46 M |
| 11/14/2022 | Q2 2023 | -$0.48 | -$0.54 | -0.06 | $2.54 M | $2.38 M |
| 08/15/2022 | Q1 2023 | -$0.78 | -$0.56 | 0.22 | $2.19 M | $2.06 M |
| 07/14/2022 | Q4 2022 | -$0.60 | -$0.70 | -0.1 | $2.11 M | $2.15 M |
| 02/14/2022 | Q3 2022 | -$0.90 | -$0.87 | 0.03 | $2.10 M | $1.93 M |
| 11/04/2021 | Q2 2022 | -$0.54 | -$1.50 | -0.96 | $1.81 M | $1.81 M |
| 08/16/2021 | Q1 2022 | N/A | -$0.87 | N/A | $1.60 M | $1.76 M |
| 06/21/2021 | Q4 2021 | N/A | -$0.86 | N/A | N/A | $1.19 M |
| 02/16/2021 | Q3 2021 | N/A | -$0.63 | N/A | N/A | $1.00 M |
Biotricity, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 25th, 2025 based offlast year's report dates.
In the previous quarter, Biotricity, Inc. (:BTCY) reported $-0.03 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.08 by $0.05.
The conference call for Biotricity, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Biotricity, Inc.'s latest earnings report can be read online.
Biotricity, Inc. (:BTCY) has a recorded annual revenue of $13.79 M.
Biotricity, Inc. (:BTCY) has a recorded net income of $-8,421,179.Biotricity, Inc. has generated $-0.55 earnings per share over the last four quarters.
Biotricity, Inc. (:BTCY) has a price-to-earnings ratio of -2.43 and price/earnings-to-growth ratio is -0.08.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED